SUBSCRIBE
SUBSCRIBE
News   Business

Beckman Coulter, Inc. Sees 2010 Profit Below Wall Street

December 18, 2009 | 
1 min read

Bookmark and Share

Reuters -- Biomedical test systems maker Beckman Coulter Inc (BEC.N) forecast fiscal 2010 earnings on Thursday in a range of $4.40 to $4.55 a share, excluding items, below the average estimate on Wall Street.

Earnings
MORE ON THIS TOPIC
Signage at Pfizer's world headquarters in New York City
Manufacturing
Pfizer Prepared to Reshore Manufacturing if Trump Makes Good on Tariff Threats
March 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
 · 
1 min read
 · 
Annalee Armstrong
Contemporary art collage of hand holding a dart aiming at the target. Business targeting, aiming, focus concept. Modern design. Copy space.
NextGen
Delphia Eyes New Precision Medicine Approach: Activation Lethality
March 4, 2025
 · 
2 min read
 · 
Annalee Armstrong
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
CRISPR, Cytiva Laying Off Employees
March 3, 2025
 · 
139 min read
 · 
BioSpace Editorial Staff